US20120003200A1 - Biologically active food supplement - Google Patents
Biologically active food supplement Download PDFInfo
- Publication number
- US20120003200A1 US20120003200A1 US13/256,237 US201013256237A US2012003200A1 US 20120003200 A1 US20120003200 A1 US 20120003200A1 US 201013256237 A US201013256237 A US 201013256237A US 2012003200 A1 US2012003200 A1 US 2012003200A1
- Authority
- US
- United States
- Prior art keywords
- vitamin
- food supplement
- leuzea
- ascorbic acid
- lactose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 32
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 20
- 244000144987 brood Species 0.000 claims abstract description 16
- 241001306755 Leuzea Species 0.000 claims abstract description 13
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 11
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 11
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 11
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 10
- 239000011709 vitamin E Substances 0.000 claims abstract description 10
- 229940046009 vitamin E Drugs 0.000 claims abstract description 10
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 10
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims abstract description 8
- 239000008116 calcium stearate Substances 0.000 claims abstract description 8
- 235000013539 calcium stearate Nutrition 0.000 claims abstract description 8
- 239000000454 talc Substances 0.000 claims abstract description 8
- 229910052623 talc Inorganic materials 0.000 claims abstract description 8
- 241000196324 Embryophyta Species 0.000 claims abstract description 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 6
- 150000002061 ecdysteroids Chemical class 0.000 claims abstract description 6
- 239000008101 lactose Substances 0.000 claims abstract description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 5
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 5
- 239000011718 vitamin C Substances 0.000 claims abstract description 5
- 239000011575 calcium Substances 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 abstract description 10
- 239000000047 product Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 4
- 230000001195 anabolic effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 241000241413 Propolis Species 0.000 description 2
- 241000606656 Silene repens Species 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229940069949 propolis Drugs 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 235000008474 Cardamine pratensis Nutrition 0.000 description 1
- 240000000606 Cardamine pratensis Species 0.000 description 1
- 235000015214 Cardamine pratensis var. angustifolia Nutrition 0.000 description 1
- 235000015213 Cardamine pratensis var. pratensis Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000940160 Klasea erucifolia Species 0.000 description 1
- 241001282601 Serratula coronata Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 238000009341 apiculture Methods 0.000 description 1
- 229940085398 ascorbic acid 50 mg Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229930195732 phytohormone Natural products 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 208000017497 prostate disease Diseases 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 150000003515 testosterones Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003568 thioethers Chemical group 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- This invention relates to the food industry, in particular, to biologically active food supplements, and is intended to build up muscle mass, for example the athletes' muscle mass.
- the best biostimulants and energy-rich products include the preparations developed based on apiculture products. There has also been known a preparation “Tonus” developed based on flower pollen and lactose, approved by the RF President Chief Sanitary Department (TU-64-02-06-244-91), and produced by Biokor Ltd.
- this preparation does not contain a multivitamin complex and vital microelements. Its effect upon the human body is governed only by the flower pollen, what may hamper the appreciation of the “Tonus” biological activity, as it is necessary to know precisely when the pollen is collected and from what plants.
- the nearest to the invention by the technical substance and achieved result is the natural multivitamin complex “Leveton”, RF Patent No. 2066963 MIIK A23L001/076.
- flower pollen (pollen load), leuzea, ascorbic acid, ⁇ -tocopheryl acetate, propolis, calcium stearate, talc and lactose with the following ratio of components (mass %): flower pollen (pollen load) 50-51, leuzea 10, ascorbic acid 3.0-3.5, ⁇ -tocopherol acetate 0.15, propolis 2, calcium stearate 0.92-0.95, talc 3, lactose—the remainder.
- Leveton has been developed to increase the athletes' strength properties and muscle mass, and has been actively used by Schools of higher sportsmanship for over 10 years. The effect of “Leveton” is caused by synergism of its components: precisely dosed vitamins and donators of phytoecdysteroids, namely, leuzea and flower pollen (pollen load). As of today, “Leveton” does not meet current requirements to rapid build-up of the muscle mass, does not ensure rapid recovery of fatigued muscles after a hard physical load.
- the flower pollen (pollen load) is suggested to be substituted by male bee brood, a substance that possesses a stronger anabolic effect than flower pollen, serves as a natural drug enabling to increase the muscle mass, protect muscles from biochemical damages and achieve maximum results.
- Male bee brood differs from the flower pollen by a larger number of functional groups of enzymes of sulphide groups, as well as hormones, namely, testosterones, progesterone and estradiol. Thanks to this set of substances, male bee brood promotes an increased restoration of biochemical and mass-metric characteristics of spermary and prostate gland, being a stimulant of central regulatory mechanisms of androgen formation intensity.
- the male bee brood increases the level of metabolism during the period of active muscle activity, owing to which physical endurance raises.
- the male bee brood contains 10 times more steroid hormones compared to the flower pollen.
- the proposed therapeutic/prophylactic product comprises male bee brood, leuzea (or other medicinal plant containing ecdysteroids), ascorbic acid (Vitamin C) and Vitamin E and excipients, the following ratio of components (mass %) being selected: male bee brood 1-70; Leuzea 5-70; ascorbic acid 1-70; vitamin E 0.05-30; excipients—the rest.
- excipients one may use for instance, calcium stearate 0.92-0.95, talc 3-6, and lactose—the remainder.
- Biochemical components of the male bee brood include: proteins 10-20%; carbohydrates 1-5.5%; fats 5-6.3%; amino acids 11.4%; glucose 3.18-5%; fructose and saccharose up to 0.5%. Its microelements include (mg %): K 0.50, Na 38, Ca 14, P 189, Mg 2, Fe 3.23, Mn 4.40%, Zn 5.54, Cu 2, Cr, Co, Ni, Ag, Au, and others.
- vitamins water- and liposoluble
- vitamins include: A 0.54 IU/g; xanthophyll 0.297 mg %; B-carotene 0.426 IU/g; B2 0.739 mg %; D 950 IU/g; choline 442.8 mg %; nicotinic acid 15.8 mg %.
- the therapeutic-prophylactic product according to the present invention is manufactured in a tablet form.
- the lower level of the content of the components is determined by the convenience of use of the proposed complex, i.e., the use of a smaller number of tablets.
- the upper level is determined by the fact that in case of greater percent ratio, it will be difficult to manufacture a tablet as it will fall to pieces.
- the proposed food supplement developed based on leuzea or another medicinal plant containing ecdysteroids
- male bee brood male bee brood
- ascorbic acid Vinecdysteroids
- Vitamin E ascorbic acid
- excipients may be used as a product for the muscle mass build-up owing to an increased content of phytoecdysteroids, phytohormones influencing the anabolic processes in an athlete's body.
- ecdysteroids-containing plants such as Serratula coronata, Serratula xeranthemoides Bieb., Cuckooflower ( Coccyganthe flos - cuculi (L.) Fourr.), Pink campion ( Silene repens ) can be used as active ingredients of the supplement proposed in the invention.
- the product not only renders an anabolic effect on the human body, but is recommended for prophylaxis in dysfunctions of the central nervous system and the prostate gland diseases and impotence as well.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Medical Informatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Animal Husbandry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009109273 | 2009-03-13 | ||
| RU2009109273/13A RU2390270C1 (ru) | 2009-03-13 | 2009-03-13 | Биологически активная добавка к пище |
| PCT/RU2010/000098 WO2010104418A1 (ru) | 2009-03-13 | 2010-03-03 | Биологически активная добавка к пище |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/RU2010/000098 A-371-Of-International WO2010104418A1 (ru) | 2009-03-13 | 2010-03-03 | Биологически активная добавка к пище |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/138,875 Continuation-In-Part US20140314870A1 (en) | 2009-03-13 | 2013-12-23 | Biologically active food supplement |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20120003200A1 true US20120003200A1 (en) | 2012-01-05 |
Family
ID=42680298
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/256,237 Abandoned US20120003200A1 (en) | 2009-03-13 | 2010-03-03 | Biologically active food supplement |
| US14/138,875 Abandoned US20140314870A1 (en) | 2009-03-13 | 2013-12-23 | Biologically active food supplement |
| US15/062,161 Active US10064421B2 (en) | 2009-03-13 | 2016-03-06 | Biologically active food supplement |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US14/138,875 Abandoned US20140314870A1 (en) | 2009-03-13 | 2013-12-23 | Biologically active food supplement |
| US15/062,161 Active US10064421B2 (en) | 2009-03-13 | 2016-03-06 | Biologically active food supplement |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20120003200A1 (ru) |
| EP (1) | EP2407035B1 (ru) |
| CN (1) | CN102791149B (ru) |
| CA (1) | CA2793071C (ru) |
| DK (1) | DK2407035T3 (ru) |
| EA (1) | EA019184B1 (ru) |
| ES (1) | ES2625294T3 (ru) |
| LT (1) | LT2407035T (ru) |
| PL (1) | PL2407035T3 (ru) |
| RU (1) | RU2390270C1 (ru) |
| UA (1) | UA108465C2 (ru) |
| WO (1) | WO2010104418A1 (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140065237A1 (en) * | 2011-03-14 | 2014-03-06 | Vyacheslav Nikolaevich Trifonov | Biologically active food additive for the prophylaxis of erectile dysfunction in men |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2414229C1 (ru) * | 2009-10-12 | 2011-03-20 | Общество С Ограниченной Ответственностью "Парафарм" | Лекарственное средство для профилактики и лечения аденомы и простатита |
| RU2425593C1 (ru) * | 2010-05-04 | 2011-08-10 | Общество С Ограниченной Ответственностью "Парафарм" | Биологически активная добавка к пище для нормализации уровня андрогенов мужчин, общего состояния, снижения ожирения |
| RU2456005C1 (ru) * | 2011-04-20 | 2012-07-20 | Общество с ограниченной ответственностью фирма "Биокор" | Способ приготовления биологически активного препарата |
| RU2493733C2 (ru) * | 2011-07-05 | 2013-09-27 | Общество С Ограниченной Ответственностью "Парафарм" | Тонизирующий напиток |
| RU2509569C2 (ru) * | 2011-07-05 | 2014-03-20 | Общество С Ограниченной Ответственностью "Парафарм" | Композиция для лечения и предупреждения остеоартрита и остеоартроза суставов |
| RU2491078C2 (ru) * | 2011-09-16 | 2013-08-27 | Общество С Ограниченной Ответственностью "Парафарм" | Способ приготовления расплода трутневого адсорбированного и его состав |
| RU2561863C1 (ru) * | 2014-03-12 | 2015-09-10 | Автономная некоммерческая организация содействия социально-экономическому развитию "ИНЖЭКОН-Тверь" | Способ изготовления биологического стимулятора |
| US9700589B2 (en) * | 2015-02-03 | 2017-07-11 | Naturex Sa | Compositions and methods for improved muscle metabolism |
| RU2577225C1 (ru) * | 2015-03-27 | 2016-03-10 | Общество С Ограниченной Ответственностью "Парафарм" | Препарат и способ для лечения дефицита андрогенов у женщин, содержащий энтомологические протеины |
| FR3078252B1 (fr) * | 2018-02-28 | 2020-08-14 | Biophytis | Phytoecdysones pour leur utilisation dans la prevention de la perte de force musculaire lors d’une immobilisation |
| RU2679361C1 (ru) * | 2018-03-29 | 2019-02-07 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет инженерных технологий" (ФГБОУ ВО "ВГУИТ") | Способ получения биогенного стимулятора для коррекции иммунного статуса сельскохозяйственных животных |
| RU2745997C1 (ru) * | 2019-11-28 | 2021-04-05 | Общество с ограниченной ответственностью "Фармацевтический завод "ГАЛЕН" | Биологически активная композиция, обладающая адаптогенным и антистрессорным действием |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2066963C1 (ru) * | 1993-10-20 | 1996-09-27 | Рошен Джафарович Сейфулла | Натуральный поливитаминный комплекс "леветон" |
| RU2233666C1 (ru) * | 2002-12-30 | 2004-08-10 | Пятигорская государственная фармацевтическая академия | Таблетки "апилар" на основе трутневого расплода, обладающие анаболическим, актопротекторным действием |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1028200C (zh) * | 1988-09-07 | 1995-04-19 | 刘本华 | 雄蜂营养素的提取方法 |
| RU1826910C (ru) * | 1991-05-12 | 1993-07-07 | В.А.Чуйко и Г.Н.Спиридонова | Биостимулирующее средство |
| CN1097308A (zh) * | 1994-04-13 | 1995-01-18 | 唐国山 | 雄蜂神液 |
| DE19627627C2 (de) * | 1996-07-09 | 2003-06-18 | Bienenzell Gmbh | Verfahren zur Herstellung eines Bienenbrutsaft-Extraktes |
| RU2149566C1 (ru) * | 1997-11-19 | 2000-05-27 | Сейфулла Рошен Джафарович | Натуральный поливитаминный комплекс "астенотон" |
| CN1274319C (zh) * | 2000-07-18 | 2006-09-13 | 沈阳药科大学 | 中药漏芦中植物甾酮类成分的用途 |
| RU2216346C1 (ru) * | 2002-06-10 | 2003-11-20 | Семенова Наталья Викторовна | Средство и способ для биогенной стимуляции организма |
-
2009
- 2009-03-13 RU RU2009109273/13A patent/RU2390270C1/ru active
-
2010
- 2010-03-03 EA EA201100167A patent/EA019184B1/ru unknown
- 2010-03-03 PL PL10751072T patent/PL2407035T3/pl unknown
- 2010-03-03 WO PCT/RU2010/000098 patent/WO2010104418A1/ru active Application Filing
- 2010-03-03 CA CA2793071A patent/CA2793071C/en active Active
- 2010-03-03 US US13/256,237 patent/US20120003200A1/en not_active Abandoned
- 2010-03-03 EP EP10751072.9A patent/EP2407035B1/en active Active
- 2010-03-03 CN CN201080011447.9A patent/CN102791149B/zh not_active Expired - Fee Related
- 2010-03-03 LT LTEP10751072.9T patent/LT2407035T/lt unknown
- 2010-03-03 UA UAA201103548A patent/UA108465C2/ru unknown
- 2010-03-03 ES ES10751072.9T patent/ES2625294T3/es active Active
- 2010-03-03 DK DK10751072.9T patent/DK2407035T3/en active
-
2013
- 2013-12-23 US US14/138,875 patent/US20140314870A1/en not_active Abandoned
-
2016
- 2016-03-06 US US15/062,161 patent/US10064421B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2066963C1 (ru) * | 1993-10-20 | 1996-09-27 | Рошен Джафарович Сейфулла | Натуральный поливитаминный комплекс "леветон" |
| RU2233666C1 (ru) * | 2002-12-30 | 2004-08-10 | Пятигорская государственная фармацевтическая академия | Таблетки "апилар" на основе трутневого расплода, обладающие анаболическим, актопротекторным действием |
Non-Patent Citations (1)
| Title |
|---|
| Oxford Dictionary under noun, number 2 on the web at http://oxforddictionaries.com/definition/english/brood 2012 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140065237A1 (en) * | 2011-03-14 | 2014-03-06 | Vyacheslav Nikolaevich Trifonov | Biologically active food additive for the prophylaxis of erectile dysfunction in men |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2407035A1 (en) | 2012-01-18 |
| ES2625294T3 (es) | 2017-07-19 |
| LT2407035T (lt) | 2017-04-10 |
| CN102791149A (zh) | 2012-11-21 |
| EA019184B1 (ru) | 2014-01-30 |
| US20140314870A1 (en) | 2014-10-23 |
| EP2407035B1 (en) | 2017-02-22 |
| RU2390270C1 (ru) | 2010-05-27 |
| PL2407035T3 (pl) | 2017-07-31 |
| US10064421B2 (en) | 2018-09-04 |
| DK2407035T3 (en) | 2017-04-10 |
| WO2010104418A1 (ru) | 2010-09-16 |
| EA201100167A1 (ru) | 2011-06-30 |
| US20160192687A1 (en) | 2016-07-07 |
| UA108465C2 (en) | 2015-05-12 |
| CA2793071C (en) | 2018-11-13 |
| CN102791149B (zh) | 2015-05-27 |
| EP2407035A4 (en) | 2013-01-02 |
| CA2793071A1 (en) | 2010-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20120003200A1 (en) | Biologically active food supplement | |
| Hoseinifar et al. | Effects of dietary polyphenols from agricultural by-products on mucosal and humoral immune and antioxidant responses of convict cichlid (Amatitlania nigrofasciata) | |
| Sirtori et al. | Nutraceuticals for blood pressure control | |
| Tuyekar et al. | An overview on coconut water: As a multipurpose nutrition | |
| Mishra et al. | Importance of dietary supplements to the health | |
| RU2376888C2 (ru) | Биологически активная добавка к пище | |
| RU2358564C1 (ru) | Порошкообразная смесь для функционального напитка "бионан-в" | |
| KR20090034803A (ko) | 근육 장애의 치료를 위한 잔톤 유도체 | |
| RU2524550C1 (ru) | Способ создания продукта спортивного питания | |
| CN112469728A (zh) | 用于提高注意功能和判断功能的组合物 | |
| RU2385660C2 (ru) | Концентрат растительный для функционального напитка "казан-бионан-2" | |
| Soliboeva | Functional food products a promising direction of new innovative technologies in dietary | |
| RU2542520C2 (ru) | Безалкогольный напиток (варианты) | |
| Mir et al. | Effect of dietary supplementation of raw fenugreek seeds (Trigonella foenum-graecum) on blood biochemical profile in goats | |
| Talib et al. | Therapeutic dose of madidihang fish bone flour and CaCO3 towards calcium and phosphorus content in blood serum and bones of ovariectomy rat | |
| RU2164766C1 (ru) | Биологически активная добавка к пище | |
| Paoli et al. | Not Only Protein: Dietary Supplements to Optimize the Skeletal Muscle Growth Response to Resistance Training: The Current State of Knowledge | |
| RU2635373C1 (ru) | Биологически активная добавка для повышения общей работоспособности | |
| Dinelli et al. | Physiologically bioactive compounds of functional foods, herbs, and dietary supplements | |
| Sawicka et al. | Plants sources of vitamins against SARS-CoV-2 | |
| Ezaldeen et al. | Effect of using two concentrations of BEDGEN 40 in drinking water at different periods on some productive characteristics in broilers. | |
| Zamir et al. | Manipulation of Dietary Intake on Changes in Circulating Testosterone Concentrations. Nutrients 2021, 13, 3375 | |
| Pozdnyakova et al. | Biologically active plant-based complex: Production technology, quality indicators, functional properties | |
| Ammatul et al. | Development of protein rich products using spirulina | |
| Vassileva | Developing compositions of medicinal plants, intended for use as additives to enrich drinks, concentrates and sauces |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |